Translating Research Into Practice



Status:Recruiting
Conditions:Breast Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:10/19/2018
Start Date:August 6, 2018
End Date:January 2022
Contact:Tracy A Battaglia, MD, MPH
Email:Tracy.Battaglia@bmc.org
Phone:617 638 7428

Use our guide to learn which trials are right for you!

Translating Research Into Practice: A Regional Collaborative to Reduce Disparities in Breast Cancer Care

The TRIP Project aims to overcome barriers to widespread implementation and dissemination of
evidence-based practices that will improve the delivery of guideline-concordant care to
vulnerable women with breast cancer. To accomplish this goal the study team will create (a)
regional patient registries; (b) systematic screening for social barriers to care with a
personalized referral plan; and (c) patient navigation services that integrate into one model
of care to improve the quality and effectiveness of care delivery, for minority and/or
low-income women with breast cancer in Boston.

This community-engaged program will demonstrate the feasibility of community-academic
partnerships to provide innovations in information sharing and systems implementation
targeted to reduce treatment disparities. Patient navigators will be able to utilize the
patient database to track their patients throughout their treatment, and receive guidance
regarding recommended social resources to patients experiencing hardships via the social
determinants platform.

Who: The four Massachusetts CTSA hubs (Boston University, Harvard University, Tufts
University, and University of Massachusetts) partnered with the Boston Breast Cancer Equity
Coalition, and the 6 hospitals that care for women with breast cancer.

Patient population: 1,100 vulnerable inner city women with risk for delay in breast cancer
care. Massachusetts (MA) Cancer Registry data identified the following characteristics of
Boston residents with greatest delays in breast cancer treatment: Black, Hispanic,
non-English speaking, and public health insurance. Six health care institutions care for >90%
of these women:

1. Beth Israel Deaconess Medical Center (site PI: Ted James, MD)

2. Boston Medical Center (PI: Tracy Battaglia MD, MPH)

3. Brigham Women's Hospital/Dana-Farber Cancer Institute (PI: Jennifer Haas MD, MPH)

4. Faulkner Hospital (site PI: Rachel Freedman, MD)

5. Massachusetts General Hospital (site PI: Beverly Moy, MD)

6. Tufts Medical Center (PI: Karen Freund MD, MPH)

UMass Medical Center (PI: Stephenie Lemon, PhD) will play an integral role in the planning
and implementation of the TRIP intervention but is not a clinical site.

Inclusion Criteria:

1. are an adult female > 18 years of age;

2. reside in the City of Boston;

3. have any of the following risk factors for delays in care: are Black and/or Hispanic
ethnicity, do not speak English as their primary language, and/or have only public
insurance or are uninsured at the time of diagnosis.

Exclusion Criteria:

1. cancer diagnosis made > 60 days prior to enrollment, such that the ability of the
intervention to effect the outcome is limited;

2. presence of a cognitive impairment such as dementia or delirium from any cause (e.g.
metabolic, medication or drug induced), given the unique challenges to their treatment
decision making/ adherence and the fact that the intervention would not include the
patient directly, but rather the family;

3. home residence is outside of the city of Boston, Massachusetts.
We found this trial at
2
sites
330 Brookline Ave
Boston, Massachusetts 02215
617-667-7000
Phone: 617-667-5509
Beth Israel Deaconess Medical Center Beth Israel Deaconess Medical Center (BIDMC) is one of the...
?
mi
from
Boston, MA
Click here to add this to my saved trials
Boston, Massachusetts 02130
Phone: 617-582-4300
?
mi
from
Boston, MA
Click here to add this to my saved trials